BALA CYNWYD, Pa., July 16, 2015 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Receptos, Inc.
("Receptos" or "the Company") (Nasdaq -RCPT-News) for possible
breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Celgene Corporation
("Celgene").
Click here to learn more about the investigation
http://brodsky-smith.com/964-rcpt-receptos-inc.html, or call:
877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Receptos shareholders will
receive only $232.00 in cash for each
share of Receptos stock they own. The investigation concerns
whether the Board of Receptos breached their fiduciary duties
to shareholders and whether Celgene is underpaying for Receptos.
The transaction may undervalue the Company given Receptos has a
strong pipeline which includes drug candidates for ulcerative
colitis, Cohn's disease, relapsing multiple sclerosis, inflammatory
bowel disease, and eosinophilic esophagitis. Consequently, an
analyst has set a price target for Receptos stock at $348.00 per share.
If you own shares of Receptos and wish to discuss the legal
ramifications of the investigation, or have any
questions, you may e-mail or call the law office of Brodsky &
Smith, LLC who will, without obligation or cost to you, attempt to
answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith,
LLC, Two Bala Plaza, Suite 510, Bala
Cynwyd, PA 19004, by visiting
http://brodsky-smith.com/964-rcpt-receptos-inc.html, or calling
toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and class action lawsuits. The attorneys at Brodsky
& Smith have been appointed by numerous courts throughout the
country to serve as lead counsel in class actions and have
successfully recovered millions of dollars for our clients and
shareholders. Attorney advertising. Prior results do not guarantee
a similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-brodsky--smith-llc-announces-investigation-of-the-board-of-directors-of-receptos-inc--rcpt-300114714.html
SOURCE Brodsky & Smith, LLC